Beruflich Dokumente
Kultur Dokumente
Article
Crosstalk between the Rb Pathway and AKT
Signaling Forms a Quiescence-Senescence Switch
Yoshinori Imai,1,2 Akiko Takahashi,1 Aki Hanyu,1 Satoshi Hori,1 Seidai Sato,1 Kazuhito Naka,3 Atsushi Hirao,3
Naoko Ohtani,1,4 and Eiji Hara1,5,*
1Division
of Cancer Biology, The Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan
School of Biomedical Science, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan
3Cancer Research Institute, Kanazawa University, Kanazawa 920-1192, Japan
4PRESTO, Japan Science Technology Agency, Saitama 332-0012, Japan
5CREST, Japan Science Technology Agency, Saitama 332-0012, Japan
*Correspondence: eiji.hara@jfcr.or.jp
http://dx.doi.org/10.1016/j.celrep.2014.03.006
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2Graduate
SUMMARY
INTRODUCTION
Over the last few decades, it has become apparent that oncogenic proliferative signals are coupled to a variety of growthinhibitory responses, such as the induction of apoptotic cell
death or irreversible cell-cycle arrest known as cellular senescence (Sharpless and DePinho, 2005). Thus, both apoptosis
and cellular senescence are thought to act as important tumorsuppression mechanisms (Campisi and dAdda di Fagagna,
2007; Collado and Serrano, 2010; Kuilman et al., 2010). However, unlike apoptotic cells, senescent cells remain viable for
long periods of time and are hypothesized to persist and accumulate with age in vivo (Krishnamurthy et al., 2004; Jeyapalan
et al., 2007; Yamakoshi et al., 2009). Thus, the irreversibility of
194 Cell Reports 7, 194207, April 10, 2014 2014 The Authors
Figure 1. Cooperation between Mitogenic Signaling and the Rb Pathway Is Required to Establish Senescent Cell-Cycle Arrest
(A) ER-p16 cells were cultured under normal conditions (1, 2, and 3) or under contact-inhibition (4, 5, and 6) or serum-starvation (7, 8, and 9) conditions for 7 days.
These cells were then cultured in the presence (2, 3, 5, 6, 8, and 9) or absence (1, 4, and 7) of 4-OHT for 7 more days. In lanes 3, 6, and 9, the cells were then
subsequently cultured under normal conditions without 4-OHT for 7 days further. The experimental conditions and representative micrographs of SA b-gal
staining and immunofluorescence staining for Flag-tagged p16 (red) are shown. DNA was stained with DAPI (blue).
(B) Total cell lysates were prepared at indicated culture conditions in (A) (lane number corresponds to culture condition in A) and were subjected to western blot
analysis using the antibodies shown left (P, phosphospecific antibody). The percentages of nuclear Flag-tagged p16 staining and SA b-gal staining in (A) are also
shown at the bottom. The representative data from three independent experiments are shown. Error bars indicate mean SD of triplicate measurements. Vinculin
was used as a loading control.
(C) ER-p16 cells cultured under the indicated conditions in (A) (3, 6, and 9) were subjected to cell proliferation analyses performed in triplicate. Error bars indicate
mean SD.
signaling plays important roles in forming a quiescencesenescence switch by regulating the functions of FoxO3a and
FoxM1 Forkhead transcription factors (Eijkelenboom and Burgering, 2013; Lam et al., 2013).
RESULTS
Mitogenic Signals Cooperate with the Rb Pathway to
Induce Cellular Senescence
To explore the molecular mechanisms underlying the cell-fate
switch between quiescence and senescence in normal human
cells, we first generated the TIG-3 strain of primary normal
196 Cell Reports 7, 194207, April 10, 2014 2014 The Authors
and 2). Note that once the senescent phenotypes were fully
induced, subsequent inactivation of the ER-p16INK4a fusion protein by the removal of 4-OHT could no longer revoke the senescent cell-cycle arrest (Figures 1A1C, 3). This was not the case
when p16INK4a was depleted by a previously validated small
interfering RNA (siRNA) prior to the 4-OHT treatment in ER-p16
cells (Figures S1A and S1B), thus confirming that these effects
were due to the activation of the p16INK4a/Rb pathway and not
to any unforeseen side effects of the 4-OHT treatment. Notably,
if the mitogenic signals were blocked by contact inhibition (Figures 1A1C, 6) or serum starvation (Figures 1A1C, 9) throughout
the 4-OHT treatment, then the vast majority of ER-p16 cells reinitiated cell proliferation as soon as normal culture conditions
(at low confluency in 10% serum medium without 4-OHT) were
restored, suggesting that cooperation between mitogenic signals and the Rb pathway is indeed required for the establishment
of senescent (irreversible) cell-cycle arrest. These results also
indicate that ER-p16 cells are an ideal model system to study
the cooperation between mitogenic signals and the Rb pathway
toward senescent cell-cycle arrest in normal human cells.
In the course of this study, we unexpectedly noted that
prolonged (more than 14 days) serum starvation induced SA
b-gal activity and enlarged cell morphology in multiple strains
of primary HDFs (Figures 1A and 1B, 7 and 8; Figures S1C
S1E). Moreover, SA b-gal activity was also detected when
ER-p16 cells were rendered quiescent by contact inhibition (Figures 1A and 1B, 4 and 5). However, because these cells immediately resumed cell proliferation as soon as the normal culture
conditions were restored (Figures 1A1C, 6 and 9; Figure S1F),
these seemingly senescent cells were actually quiescent, rather
than senescent. These results are somewhat consistent with previous observations that the SA b-gal activity and the enlarged cell
morphology are not always associated with cellular senescence
(Dimri et al., 1995; Lin et al., 1998). Thus, we decided not to use
these markers for the detection of senescent cells in the following
experiments in this study. Nevertheless, these results further
support the idea that cooperation between mitogenic signals
the antibodies shown on the left (P, phosphospecific antibody) or to analysis of nuclear Flag-tagged p16 staining. Representative data from three independent
experiments are shown. b-actin was used as a loading control. Error bars indicate mean SD of triplicate measurements.
(B) ER-p16 cells cultured under the indicated conditions in (A) (3, 6, and 9) were subjected to cell proliferation analysis performed in triplicate. Error bars indicate
mean SD.
(C) Enrichment of gH2AX at subtelomeric regions was assayed on chromosome 12p by ChIP assay followed by real-time PCR using previously validated primers
at indicated distances from the chromosome end. The graph shows log2 ratios of ER-p16 cells treated with or without 4-OHT. Each PCR reaction was performed
in triplicate, and the average positions are plotted (n = 2).
(D) ER-p16 cells were subjected to transfection with siRNA oligos against either control (1, 2, and 3), ATM sequence 1 (4, 5, and 6), or ATM sequence 2 (7, 8, and 9)
three times (at 2-day intervals) throughout 4-OHT treatment (2, 3, 5, 6, 8, and 9) or mock treatment (1, 4, and 7) for 7 days. In lanes 3, 6, and 9, the cells were
then subsequently cultured under normal conditions without 4-OHT and siRNA oligos for 7 more days. These cells were subjected either to western blotting using
the antibodies shown on the left (P, phosphospecific antibody) or to analysis of nuclear Flag-tagged p16 staining. The percentages of nuclear Flag-tagged
p16INK4a-positive cells are also shown at the bottom. Representative data from three independent experiments are shown. Error bars indicate mean SD of
triplicate measurements. b-actin was used as a loading control.
(E) ER-p16 cells cultured under the conditions indicated in (D) (3, 6, and 9) were subjected to cell proliferation analysis performed in triplicate. Error bars indicate
means SD.
(F) ER-p16 cells were cultured under the normal conditions with (4, 5, and 6) or without (1, 2, and 3) 1 mM of NAC for 7 days. These cells were then cultured in the
presence (2, 3, 5, and 6) or absence (1 and 4) of 4-OHT for 7 more days. In lanes 3 and 6, the cells were then subsequently cultured under normal conditions
without 4-OHT and NAC for 7 days further. These cells were then subjected either to western blotting using the antibodies shown on the left (P, phosphospecific
antibody) or to analysis of nuclear Flag-tagged p16 staining and ROS intracellular levels. Representative data from three independent experiments are shown.
b-actin was used as a loading control. Error bars indicate mean SD of triplicate measurements.
(G) ER-p16 cells cultured under the conditions indicated in (F) (3 and 6) were subjected to cell proliferation analyses performed in triplicate. Error bars indicate
mean SD.
Cell Reports 7, 194207, April 10, 2014 2014 The Authors 197
198 Cell Reports 7, 194207, April 10, 2014 2014 The Authors
ure S2A), it seems possible that SOD2, but not SOD1 or SOD3,
plays key role in detoxifying ROS in ER-p16 cells. Collectively,
these results indicated that mitogenic signaling cooperates
with the p16INK4a/Rb pathway to increase the intracellular ROS
levels through the reduction of SOD2 expression via AKT-dependent inactivation of FoxO3a, leading to an irreparable DDR and
consequent senescent (irreversible) cell-cycle arrest.
FoxO3a Binds to the FBEs in the SOD2 Gene Promoter in
Quiescent Cells, but Not in Senescent Cells
We therefore next examined the regulation of SOD2 gene
expression by FoxO3a. There are five putative Forkhead transcription factor-binding elements (FBEs) within the human
SOD2 gene promoter. A promoter reporter analysis and electrophoretic mobility shift analysis (EMSA) revealed that the FBEs
at 1,292 (FBE-2), 1,268 (FBE-3), and 1,181 (FBE-4) upstream of the transcription start site respond to the ectopic
expression of FoxO3a-TM (Figure 4A, 1, 2, 9, 10, 13, 15, 16,
and 17 and data not shown). Concordantly, moreover, endogenous FoxO3a only bound to these FBEs if the mitogenic signaling
was blocked by culturing under high-density or serum-starvation
conditions (Figures 4B and 4C, 2 and 3). These observations
support our idea that mitogenic signaling works cooperatively
with the p16INK4a/Rb pathway to increase the intracellular ROS
levels through the AKT-dependent inactivation of FoxO3a in senescent cells. However, given that FoxO3a is inactivated by AKT
in proliferating cells, it was puzzling that SOD2 expression was
maintained in proliferating cells (Figures S2AS2C, 1, 6 and 9).
Because SOD2 expression was repressed when the p16INK4a/
Rb pathway was activated in the presence of AKT signaling (Figure S2A, 2) and Rb is known to play key roles in repressing the
E2F target genes in senescent cells (Chicas et al., 2010), we
reasoned that the SOD2 expression may be maintained by the
E2F transcription factor in proliferating cells. Unexpectedly,
however, we were unable to find a consensus E2F recognition
sequence within 10 kb upstream of the transcription start site
of the human SOD2 gene promoter, implying that E2F may indirectly regulate SOD2 gene expression in proliferating cells.
FoxM1 Can Substitute for FoxO3a in Proliferating Cells
To substantiate this idea, we searched for evidence that the
E2F target gene product acts as a substitute for FoxO3a in proliferating cells. Combining multiple data sets of DNA microarray
analyses, we found FoxM1, another member of the Forkhead
transcription factor family (Lam et al., 2013), as a strong candidate. Its mRNA expression is commonly reduced when senescent cell-cycle arrest is induced by serial passage (replicative
senescence), oncogenic Ras expression (Ras-induced senescence), depletion of DP1 (an essential activator of E2F transcription factors), or p16INK4a expression (ER-p16 cells treated with
4OHT) in HDFs (Figures S4A and S4B). We also confirmed that
both E2F1 and E2F3 bound to and activated FoxM1 gene promoter in proliferating HDFs (data not shown). These results, in
in (A) and ROS levels are also shown at the bottom. Representative data from three independent experiments are shown. Error bars indicate mean SD of
triplicate measurements. b-actin was used as a loading control.
(C) ER-p16 cells cultured under the conditions indicated in (A) (3, 6, and 9) were subjected to cell proliferation analysis performed in triplicate. Error bars indicate
mean SD.
Cell Reports 7, 194207, April 10, 2014 2014 The Authors 199
Figure 4. FoxO3a and FoxM1 Regulate Human SOD2 Gene Promoter Activity
(A) Schematic representation of the reporter constructs of human SOD2 gene promoter used in the promoter-reporter analysis (left panel). The Forkhead
transcription factor-binding elements (FBEs) were at the following locations from the transcription start site are shown as black rectangles: FBE-1 (from 4,987
to 4,980), FBE-2 (from 1,292 to 1,285), FBE-3 (from 1,268 to 1,261), FBE-4 (from 1,181 to 1,174), and FBE-5 (from 928 to 921). The white rectangles on the promoter scheme indicate the deletion of the FBE sites. U2OS cells were transiently cotransfected with the indicated luciferase reporter constructs
200 Cell Reports 7, 194207, April 10, 2014 2014 The Authors
cytes are nonproliferating cells, they retain their ability to proliferate and regenerate damaged hepatic tissue after toxic injury
and/or infections, indicating that adult hepatocytes are in the
quiescent state (Fausto, 2004). In contrast, age-related defects
in hepatocyte proliferation are known to be associated with the
appearance of multiples senescence markers, such as accumulation of DNA damage foci, increased expression of p16INK4a,
and diminished expression of FoxM1 (Krishnamurthy et al.,
2004; Wang et al., 2001, 2009; Yamakoshi et al., 2009), suggesting that aged hepatocytes are likely to be in the senescent state.
These notions, together with the observation that the ectopic
expression of FoxM1 in mouse hepatocytes prevented the
progression of age-related proliferation defects (Wang et al.,
2001), prompted us to examine whether the FoxM1/FoxO3aROS-DDR pathway plays a role in forming a quiescence-senescence switch in hepatocytes in vivo.
In the livers of juvenile mice, a significant proportion of hepatocytes are positive for Ki67 expression (a proliferation marker)
(Figures 5A and 5B, 1 and 2), and we detected substantial levels
of FoxM1, but not FoxO3a, bound to the regions of functional
FBEs (FEB-4 and FEB-5) of the mouse SOD2 gene promoter
(Figure 5C, 1 and 2; Figure S5, 1 and 6). In the livers of young
adult mice, in which most of the hepatocytes are in the quiescent
state (Figures 5A and 5B, 3 and 4), FoxO3a, but not FoxM1, was
bound to the same region of the mouse SOD2 gene promoter
(Figure 5C, 3 and 4). This was accompanied by reduced
FoxM1 expression, diminished AKT phosphorylation, and
consequent nuclear accumulation (activation) of FoxO3a in the
livers of young adult mice (Figures 5A and 5B, 3 and 4). Note
that lower SOD2 expression was observed in the livers of young
adult mice lacking the FoxO3a gene, accompanied by increased
ROS levels and DNA damage foci (gH2AX and 53BP1) accumulation (Figures 6A6C, 5 and 6). Thus, although other mechanisms may also be involved, the simplest explanation for this
result is that FoxO3a acts as a substitute for FoxM1 in preventing
the elevation of ROS levels and the consequent onset of cellular
senescence by maintaining SOD2 expression in the quiescent
hepatocytes of young adult mice livers. Importantly, neither
FoxM1 nor FoxO3a bound to the SOD2 gene promoter in the
livers of older mice (Figure 5C, 5 and 6), coinciding with the
reduction of both FoxM1 expression level and the nuclear
FoxO3a level (Figures 5A and 5B, 5 and 6). Concordantly, the
signs of cellular senescence, such as increase of p16INK4a
expression, reduction of SIRT1 expression, decreased SOD2
levels, elevated ROS levels, and accumulation of DNA damage
foci (Abdelmohsen et al., 2007; Kuilman et al., 2010), were all
observed in the livers of older mice (Figures 5A and 5B, 5
and 6). Notably, moreover, the levels of AKT phosphorylation
and expression vectors (right panel). Firefly luciferase activity was normalized to the activity of cotransfected Renilla luciferase. The experiments were performed
in triplicate, and representative results from three independent experiments are shown in the right panel. Error bars indicate mean SD of triplicate measurements.
(BD) The positions of the PCR primers for the ChIP analysis are shown at the top of the panel (red arrows). ER-p16 cells were cultured under normal conditions
(1, 4, and 5) or under contact-inhibition (2) or serum-starvation (3) conditions for 7 days. The cells were then cultured in the presence (2, 3, 4, and 5) or absence (1)
of 4-OHT for 7 more days. In lane 5, the cells were then subsequently cultured under normal conditions without 4-OHT for 7 days further. These cells were
subjected to ChIP analysis using antibodies against control immunoglobulin G (black), FoxO3a (red), or FoxM1 (green), and the PCR primers are shown at the top
(red). A schematic representation of the FBEs (black rectangles) in the human SOD2 gene promoter region is shown at the top of the panels. The experiments were
performed in triplicate, and representative results from three independent experiments are shown. Error bars indicate mean SD of triplicate measurements.
Cell Reports 7, 194207, April 10, 2014 2014 The Authors 201
Figure 5. Complementary Roles of FoxO3a and FoxM1 in Preventing Hepatocyte Senescence In Vivo
(A) Hematoxylin and eosin (H&E) staining and immunohistochemistry for endogenous p16INK4aexpression, Ki67 expression, FoxO3a expression, gH2AX foci,
and 53BP1 foci were performed using biopsy samples of livers from 3-week-old (1 and 2), 24-week-old (3 and 4), and 109-week-old (5 and 6) wild-type female
CD-1 mice.
(B) Biopsy samples of livers from 3-week-old, 24-week-old, and 109-week-old wild-type female CD-1 mice were subjected to western blot analysis using the
antibodies shown on the left or to the analysis of ROS intracellular levels (lane number corresponds to that in A) (P, phosphospecific antibody). Vinculin was used
as a loading control. The percentages of positively stained cells in (A) are also shown at the bottom. Error bars indicate mean SD of triplicate measurements.
(C) Indicated mouse livers were subjected to the ChIP analysis using antibodies against control immunoglobulin G (black), FoxO3a (red), or FoxM1 (green), and
PCR primers are shown at the top (red arrows). A schematic representation of the FBEs (black rectangles) in the mouse SOD2 gene promoter region is shown at
the top of the panels (see also Figure S5). Experiments were performed in triplicate, and representative results from three independent experiments are shown.
Error bars indicate mean SD of triplicate measurements.
202 Cell Reports 7, 194207, April 10, 2014 2014 The Authors
Cell Reports 7, 194207, April 10, 2014 2014 The Authors 203
ACCESSION NUMBERS
Microarray data have been deposited to the NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/gds) under the accession numbers GSE49860,
GSE49861, GSE49862, and GSE49863.
SUPPLEMENTAL INFORMATION
Immunoblotting and Immunoprecipitation Analysis
Immunoprecipitation and immunoblotting were performed as previously
described (Takahashi et al., 2012). The antibodies used are listed in Supplemental Experimental Procedures.
Cell Reports 7, 194207, April 10, 2014 2014 The Authors 205
ACKNOWLEDGMENTS
We thank the SCADS Inhibitor Kit Screening Committee supported by the
Ministry of Education, Culture, Sports, Science and Technology (MEXT) for
providing us with SCADS inhibitor kits. This work was supported by grants
from the Japan Science and Technology Agency (JST), MEXT, and the Ministry
of Health, Labour, and Welfare of Japan (MHLW). Y.I. was supported by a
fellowship from the Japan Society for Promotion of Science (JSPS).
Received: October 12, 2013
Revised: January 13, 2014
Accepted: March 3, 2014
Published: April 3, 2014
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C.,
Schurra, C., Garre, M., Nuciforo, P.G., Bensimon, A., et al. (2006). Oncogeneinduced senescence is a DNA damage response triggered by DNA hyperreplication. Nature 444, 638642.
Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano,
E.E., Linskens, M., Rubelj, I., Pereira-Smith, O., et al. (1995). A biomarker that
identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl.
Acad. Sci. USA 92, 93639367.
Eijkelenboom, A., and Burgering, B.M. (2013). FOXOs: signalling integrators
for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 8397.
Fausto, N. (2004). Liver regeneration and repair: hepatocytes, progenitor cells,
and stem cells. Hepatology 39, 14771487.
REFERENCES
Abdelmohsen, K., Pullmann, R., Jr., Lal, A., Kim, H.H., Galban, S., Yang, X.,
Blethrow, J.D., Walker, M., Shubert, J., Gillespie, D.A., et al. (2007). Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 25, 543557.
Fumagalli, M., Rossiello, F., Clerici, M., Barozzi, S., Cittaro, D., Kaplunov, J.M.,
Bucci, G., Dobreva, M., Matti, V., Beausejour, C.M., et al. (2012). Telomeric
DNA damage is irreparable and causes persistent DNA-damage-response
activation. Nat. Cell Biol. 14, 355365.
Anders, L., Ke, N., Hydbring, P., Choi, Y.J., Widlund, H.R., Chick, J.M., Zhai,
H., Vidal, M., Gygi, S.P., Braun, P., and Sicinski, P. (2011). A systematic screen
for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20, 620634.
Baker, D.J., and Sedivy, J.M. (2013). Probing the depths of cellular senescence. J. Cell Biol. 202, 1113.
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N.,
Vassiliou, L.V., Kolettas, E., Niforou, K., Zoumpourlis, V.C., et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by
DNA damage checkpoints. Nature 444, 633637.
Beausejour, C.M., Krtolica, A., Galimi, F., Narita, M., Lowe, S.W., Yaswen, P.,
and Campisi, J. (2003). Reversal of human cellular senescence: roles of the
p53 and p16 pathways. EMBO J. 22, 42124222.
Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., Anderson,
M.J., Arden, K.C., Blenis, J., and Greenberg, M.E. (1999). Akt promotes cell
survival by phosphorylating and inhibiting a Forkhead transcription factor.
Cell 96, 857868.
Campisi, J., and dAdda di Fagagna, F. (2007). Cellular senescence: when bad
things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729740.
Chandler, H., and Peters, G. (2013). Stressing the cell cycle in senescence and
aging. Curr. Opin. Cell Biol. 25, 765771.
Cheung, T.H., and Rando, T.A. (2013). Molecular regulation of stem cell quiescence. Nat. Rev. Mol. Cell Biol. 14, 329340.
Chicas, A., Wang, X., Zhang, C., McCurrach, M., Zhao, Z., Mert, O., Dickins,
R.A., Narita, M., Zhang, M., and Lowe, S.W. (2010). Dissecting the unique
role of the retinoblastoma tumor suppressor during cellular senescence.
Cancer Cell 17, 376387.
Lam, E.W., Brosens, J.J., Gomes, A.R., and Koo, C.Y. (2013). Forkhead
box proteins: tuning forks for transcriptional harmony. Nat. Rev. Cancer 13,
482495.
Coppe, J.P., Rodier, F., Patil, C.K., Freund, A., Desprez, P.Y., and Campisi, J.
(2011). Tumor suppressor and aging biomarker p16INK4a induces cellular
senescence without the associated inflammatory secretory phenotype.
J. Biol. Chem. 286, 3639636403.
Lee, A.C., Fenster, B.E., Ito, H., Takeda, K., Bae, N.S., Hirai, T., Yu, Z.X.,
Ferrans, V.J., Howard, B.H., and Finkel, T. (1999). Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol.
Chem. 274, 79367940.
dAdda di Fagagna, F. (2008). Living on a break: cellular senescence as a DNAdamage response. Nat. Rev. Cancer 8, 512522.
Lee, B.Y., Han, J.A., Im, J.S., Morrone, A., Johung, K., Goodwin, E.C., Kleijer,
W.J., DiMaio, D., and Hwang, E.S. (2006). Senescence-associated b-galactosidase is lysosomal b-galactosidase. Aging Cell 5, 187195.
dAdda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P.,
Von Zglinicki, T., Saretzki, G., Carter, N.P., and Jackson, S.P. (2003). A DNA
damage checkpoint response in telomere-initiated senescence. Nature 426,
194198.
Dai, C.Y., and Enders, G.H. (2000). p16INK4a can initiate an autonomous
senescence program. Oncogene 19, 16131622.
Dannenberg, J.H., van Rossum, A., Schuijff, L., and te Riele, H. (2000). Ablation
of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes
Dev. 14, 30513064.
206 Cell Reports 7, 194207, April 10, 2014 2014 The Authors
Lin, A.W., Barradas, M., Stone, J.C., van Aelst, L., Serrano, M., and Lowe, S.W.
(1998). Premature senescence involving p53 and p16 is activated in response
to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 30083019.
Litovchick, L., Florens, L.A., Swanson, S.K., Washburn, M.P., and DeCaprio,
J.A. (2011). DYRK1A protein kinase promotes quiescence and senescence
through DREAM complex assembly. Genes Dev. 25, 801813.
Ming, M., Shea, C.R., Guo, X., Li, X., Soltani, K., Han, W., and He, Y.Y. (2010).
Regulation of global genome nucleotide excision repair by SIRT1 through
xeroderma pigmentosum C. Proc. Natl. Acad. Sci. USA 107, 2262322628.
Miyamoto, K., Araki, K.Y., Naka, K., Arai, F., Takubo, K., Yamazaki, S.,
Matsuoka, S., Miyamoto, T., Ito, K., Ohmura, M., et al. (2007). Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1,
101112.
Miyauchi, H., Minamino, T., Tateno, K., Kunieda, T., Toko, H., and Komuro, I.
(2004). Akt negatively regulates the in vitro lifespan of human endothelial cells
via a p53/p21-dependent pathway. EMBO J. 23, 212220.
Moiseeva, O., Bourdeau, V., Roux, A., Deschenes-Simard, X., and Ferbeyre,
G. (2009). Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol. Cell. Biol. 29, 44954507.
~nez, S., Heard, E., Narita, M., Lin, A.W., Hearn, S.A., Spector,
Narita, M., Nu
D.L., Hannon, G.J., and Lowe, S.W. (2003). Rb-mediated heterochromatin
formation and silencing of E2F target genes during cellular senescence. Cell
113, 703716.
Naylor, R.M., Baker, D.J., and van Deursen, J.M. (2013). Senescent cells: a
novel therapeutic target for aging and age-related diseases. Clin. Pharmacol.
Ther. 93, 105116.
Nogueira, V., Park, Y., Chen, C.C., Xu, P.Z., Chen, M.L., Tonic, I., Unterman, T.,
and Hay, N. (2008). Akt determines replicative senescence and oxidative or
oncogenic premature senescence and sensitizes cells to oxidative apoptosis.
Cancer Cell 14, 458470.
Park, H.J., Carr, J.R., Wang, Z., Nogueira, V., Hay, N., Tyner, A.L., Lau, L.F.,
Costa, R.H., and Raychaudhuri, P. (2009). FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 28, 29082918.
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., and Campisi, J.
(2003). Oxygen sensitivity severely limits the replicative lifespan of murine
fibroblasts. Nat. Cell Biol. 5, 741747.
Sang, L., Coller, H.A., and Roberts, J.M. (2008). Control of the reversibility of
cellular quiescence by the transcriptional repressor HES1. Science 321,
10951100.
Satyanarayana, A., Greenberg, R.A., Schaetzlein, S., Buer, J., Masutomi, K.,
Hahn, W.C., Zimmermann, S., Martens, U., Manns, M.P., and Rudolph, K.L.
(2004). Mitogen stimulation cooperates with telomere shortening to activate
DNA damage responses and senescence signaling. Mol. Cell. Biol. 24,
54595474.
Severino, J., Allen, R.G., Balin, S., Balin, A., and Cristofalo, V.J. (2000). Is
b-galactosidase staining a marker of senescence in vitro and in vivo? Exp.
Cell Res. 257, 162171.
Sharpless, N.E., and DePinho, R.A. (2005). Cancer: crime and punishment.
Nature 436, 636637.
Takahashi, A., Ohtani, N., Yamakoshi, K., Iida, S., Tahara, H., Nakayama, K.,
Nakayama, K.I., Ide, T., Saya, H., and Hara, E. (2006). Mitogenic signalling
and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8, 12911297.
Takahashi, A., Imai, Y., Yamakoshi, K., Kuninaka, S., Ohtani, N., Yoshimoto,
S., Hori, S., Tachibana, M., Anderton, E., Takeuchi, T., et al. (2012). DNA
damage signaling triggers degradation of histone methyltransferases through
APC/CCdh1 in senescent cells. Mol. Cell 45, 123131.
Takai, H., Smogorzewska, A., and de Lange, T. (2003). DNA damage foci at
dysfunctional telomeres. Curr. Biol. 13, 15491556.
van den Heuvel, S., and Dyson, N.J. (2008). Conserved functions of the pRB
and E2F families. Nat. Rev. Mol. Cell Biol. 9, 713724.
Passos, J.F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C.J.,
Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010). Feedback
between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 6, 347.
Wang, X., Quail, E., Hung, N.J., Tan, Y., Ye, H., and Costa, R.H. (2001).
Increased levels of forkhead box M1B transcription factor in transgenic mouse
hepatocytes prevent age-related proliferation defects in regenerating liver.
Proc. Natl. Acad. Sci. USA 98, 1146811473.
Ramirez, R.D., Morales, C.P., Herbert, B.S., Rohde, J.M., Passons, C., Shay,
J.W., and Wright, W.E. (2001). Putative telomere-independent mechanisms
of replicative aging reflect inadequate growth conditions. Genes Dev. 15,
398403.
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin-Ruiz, C., and von Zglinicki,
T. (2009). DNA damage response and cellular senescence in tissues of aging
mice. Aging Cell 8, 311323.
Rodier, F., and Campisi, J. (2011). Four faces of cellular senescence. J. Cell
Biol. 192, 547556.
Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y.,
Mann, D.J., Ohmura, M., Hirao, A., Saya, H., et al. (2009). Real-time in vivo
imaging of p16Ink4a reveals cross talk with p53. J. Cell Biol. 186, 393407.
Sage, J., Mulligan, G.J., Attardi, L.D., Miller, A., Chen, S., Williams, B., Theodorou, E., and Jacks, T. (2000). Targeted disruption of the three Rb-related
genes leads to loss of G1 control and immortalization. Genes Dev. 14, 3037
3050.
Yegorov, Y.E., Akimov, S.S., Hass, R., Zelenin, A.V., and Prudovsky, I.A.
(1998). Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp. Cell Res. 243, 207211.
Cell Reports 7, 194207, April 10, 2014 2014 The Authors 207